Linden Thomas Advisory Services LLC Has $479,000 Position in National Research Co. (NASDAQ:NRC)

Linden Thomas Advisory Services LLC reduced its stake in National Research Co. (NASDAQ:NRC) by 3.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 27,157 shares of the company’s stock after selling 907 shares during the quarter. Linden Thomas Advisory Services LLC owned approximately 0.12% of National Research worth $479,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in NRC. Millennium Management LLC lifted its holdings in National Research by 200.9% in the 2nd quarter. Millennium Management LLC now owns 214,858 shares of the company’s stock worth $4,931,000 after purchasing an additional 143,454 shares during the last quarter. Hotchkis & Wiley Capital Management LLC bought a new stake in shares of National Research during the third quarter valued at approximately $3,158,000. Marshall Wace LLP bought a new stake in shares of National Research during the second quarter valued at approximately $1,644,000. Algert Global LLC increased its position in shares of National Research by 94.0% during the third quarter. Algert Global LLC now owns 82,921 shares of the company’s stock valued at $1,896,000 after purchasing an additional 40,182 shares during the period. Finally, Squarepoint Ops LLC bought a new stake in shares of National Research during the second quarter valued at approximately $845,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.

National Research Stock Performance

NRC opened at $17.96 on Monday. The stock has a market cap of $421.70 million, a PE ratio of 15.89 and a beta of 0.53. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. National Research Co. has a 1 year low of $16.50 and a 1 year high of $42.00. The stock’s 50 day simple moving average is $18.15 and its 200-day simple moving average is $20.24.

National Research (NASDAQ:NRC) last released its quarterly earnings data on Friday, October 25th. The company reported $0.24 earnings per share (EPS) for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The business had revenue of $35.82 million for the quarter.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.